These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 33808773)
1. Nutraceutical Screening in a Zebrafish Model of Muscular Dystrophy: Gingerol as a Possible Food Aid. Licitra R; Marchese M; Brogi L; Fronte B; Pitto L; Santorelli FM Nutrients; 2021 Mar; 13(3):. PubMed ID: 33808773 [TBL] [Abstract][Full Text] [Related]
2. β-Glucans as Dietary Supplement to Improve Locomotion and Mitochondrial Respiration in a Model of Duchenne Muscular Dystrophy. Brogi L; Marchese M; Cellerino A; Licitra R; Naef V; Mero S; Bibbiani C; Fronte B Nutrients; 2021 May; 13(5):. PubMed ID: 34065946 [TBL] [Abstract][Full Text] [Related]
3. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy. Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404 [TBL] [Abstract][Full Text] [Related]
4. Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment. Li M; Andersson-Lendahl M; Sejersen T; Arner A FASEB J; 2014 Apr; 28(4):1593-9. PubMed ID: 24371125 [TBL] [Abstract][Full Text] [Related]
5. PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA. Lambert MR; Spinazzola JM; Widrick JJ; Pakula A; Conner JR; Chin JE; Owens JM; Kunkel LM Mol Ther; 2021 Mar; 29(3):1086-1101. PubMed ID: 33221436 [TBL] [Abstract][Full Text] [Related]
7. A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy. Farr GH; Morris M; Gomez A; Pham T; Kilroy E; Parker EU; Said S; Henry C; Maves L Skelet Muscle; 2020 Oct; 10(1):29. PubMed ID: 33059738 [TBL] [Abstract][Full Text] [Related]
8. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
10. Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy. Widrick JJ; Alexander MS; Sanchez B; Gibbs DE; Kawahara G; Beggs AH; Kunkel LM Physiol Genomics; 2016 Nov; 48(11):850-860. PubMed ID: 27764767 [No Abstract] [Full Text] [Related]
11. Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy. Hildyard JCW; Taylor-Brown F; Massey C; Wells DJ; Piercy RJ J Neuromuscul Dis; 2018; 5(2):177-191. PubMed ID: 29614692 [TBL] [Abstract][Full Text] [Related]
12. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy. Echigoya Y; Lim KRQ; Trieu N; Bao B; Miskew Nichols B; Vila MC; Novak JS; Hara Y; Lee J; Touznik A; Mamchaoui K; Aoki Y; Takeda S; Nagaraju K; Mouly V; Maruyama R; Duddy W; Yokota T Mol Ther; 2017 Nov; 25(11):2561-2572. PubMed ID: 28865998 [TBL] [Abstract][Full Text] [Related]
13. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20. Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823 [TBL] [Abstract][Full Text] [Related]
14. Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture. Woodman KG; Coles CA; Lamandé SR; White JD Nutrients; 2016 Nov; 8(11):. PubMed ID: 27834844 [TBL] [Abstract][Full Text] [Related]
15. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice. Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436 [TBL] [Abstract][Full Text] [Related]
16. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model. Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519 [TBL] [Abstract][Full Text] [Related]
17. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy. Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826 [TBL] [Abstract][Full Text] [Related]
18. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models. van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492 [TBL] [Abstract][Full Text] [Related]
19. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies. Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331 [TBL] [Abstract][Full Text] [Related]
20. SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy. Sarathy A; Wuebbles RD; Fontelonga TM; Tarchione AR; Mathews Griner LA; Heredia DJ; Nunes AM; Duan S; Brewer PD; Van Ry T; Hennig GW; Gould TW; Dulcey AE; Wang A; Xu X; Chen CZ; Hu X; Zheng W; Southall N; Ferrer M; Marugan J; Burkin DJ Mol Ther; 2017 Jun; 25(6):1395-1407. PubMed ID: 28391962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]